Your session is about to expire
← Back to Search
Behavioral Intervention
CALM Therapy for Primary Brain Tumor Distress
N/A
Waitlist Available
Led By Terri S Armstrong, C.R.N.P.
Research Sponsored by National Cancer Institute (NCI)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 and 6 months compared to baseline
Awards & highlights
Study Summary
This trial is testing whether the CALM therapy can help people with a CNST suffering from distress. English-speaking adults with a CNST may be eligible. The study will be done by smartphone, computer, or tablet.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 and 6 months compared to baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 and 6 months compared to baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
feasibility of implementing CALM remotely
reduction of anxiety score using the Death and Dying Distress Scale (DADDS)
reduction of depressive symptoms using the PROMIS-Depression scale in PCNST participants
Trial Design
1Treatment groups
Experimental Treatment
Group I: Arm 1Experimental Treatment1 Intervention
Remote CALM therapy for participants with newly or recurrent PCNST
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)Lead Sponsor
13,717 Previous Clinical Trials
40,953,301 Total Patients Enrolled
82 Trials studying Depression
66,110 Patients Enrolled for Depression
Terri S Armstrong, C.R.N.P.Principal InvestigatorNational Cancer Institute (NCI)
5 Previous Clinical Trials
1,588 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have confirmed brain or spinal cord cancer and are currently receiving standard treatment or taking part in a research study.
Research Study Groups:
This trial has the following groups:- Group 1: Arm 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger